Anxiety and depression associated with migraine: Influence on migraine subjects' disability and quality of life, and acute migraine management

Lantéri-Minet, Michel; Radat, F.; Chautard, Marie-Hélène; Lucas, Christian

doi:10.1016/j.pain.2005.09.010

Cited by 283 publications

(307 citation statements)

References 28 publications

Supporting

Mentioning

263

Contrasting

Unclassified

Order By: Relevance

“…However, little is known about the impact of anxiety and depression on migraine-related disability and quality of life. Lantéri-Minet et al [12] found increased migraine disability and greater impairment in HRQOL when migraine was associated with anxiety and depression. The complex interaction of such characteristic psychiatric disorders with migraine subjects' well-being and functional status is poorly understood and under-recognised.…”

mentioning

confidence: 98%

Health-related quality of life among Canadians with migraine

2006

View full text Add to dashboard Cite

The objective was to determine the impact of migraine on health-related quality of life (HRQOL) among Canadians. Analysis was based on the public use microdata set of the Canadian Community Health Survey (CCHS), limited to those aged ≥5 residing in Manitoba. HRQOL was measured using the SF-36 survey, which covers 8 health concepts. Multivariate linear regression was used to model each SF-36 scale against age, gender, education, income, migraine status and presence of mood or anxiety disorders. Of the 7236 CCHS respondents, 9.7% reported a diagnosis of migraine. Reported migraine predicted statistically significant ( p <0.0001) lower HRQOL in all SF-36 domains with profound impairment of physical role, bodily pain and general health. Those reporting a mood disorder scored significantly lower in all domains with pronounced effects on emotional role, social functioning and general health. Reported anxiety disorder was associated with lower HRQOL in 6/8 domains. Canadians with migraine report significant impairment in HRQOL compared to the general population, independent of psychiatric morbidity.

show abstract

mentioning

confidence: 98%

Health-related quality of life among Canadians with migraine

2006

View full text Add to dashboard Cite

show abstract

“…The impact of anxiety and depression on migraine was highlighted by a recent landmark study of the French population by Lantéri-Minet et al 12 Using a low threshold on the Hospital Anxiety and Depression Scale (HADS), they found that 51% of subjects with active migraine were anxious or depressed, but importantly 28% had anxiety alone. Depression alone was not found to be more frequent among migraine than non-migraine subjects in this survey, and screening for depression alone would have missed over half of those with significant psychiatric comorbidity.…”

Section: Discussion and Screening Recommendationsmentioning

confidence: 99%

“…11 Migraineurs with anxiety and depression also report lower satisfaction with headache treatment, increased headache-related disability, and reduced quality-oflife than do migraineurs with neither comorbid condition. 12 An emerging body of literature suggests that psychiatric comorbidity also portends a poorer prognosis for response to headache treatment. 2,13 Despite this evidence, there is a relative paucity of research investigating the effects of treating psychiatric disorders on headache or the converse, on the impact of treating headache on psychiatric disorders.…”

Section: Why Screen For Psychiatric Disorders?mentioning

confidence: 99%

A Review of Screening Tools for Psychiatric Comorbidity in Headache Patients

Maizels

Smitherman²,

Penzien³

2006

Headache

View full text Add to dashboard Cite

Psychiatric comorbidity, especially depression and anxiety, has been well documented in patients with primary headache disorders. The presence of psychiatric comorbidity in headache patients is associated with decreased quality-of-life, poorer prognosis, chronification of disease, poorer response to treatment, and increased medical costs. Despite the prevalence and impact, screening for psychiatric disorders in headache patients is not systematically performed, either clinically or in research studies, and there are no guidelines to suggest which patients should be screened or in what manner. We review a variety of screening methods and instruments, focusing primarily on self-report measures and those available in the public domain. Informal verbal screening may be sufficient in a primary care setting, but should include screening for both anxiety and depression. Explicit screening for anxiety is important, as anxiety may have a more significant impact on headache than does depression and may occur in the absence of clinical depression. Formal screening with instruments that can identify a variety of psychiatric disorders is appropriate for patients with daily headache syndromes, patients who are refractory to usual care, and patients referred for specialty evaluation. Limitations of screening instruments include the influence of transdiagnostic symptoms and the need for confirmatory diagnostic interview. The following instruments appear most suitable for use in headache patients: for depression,

show abstract

“…In another population based study in France, more than half of the migraine sufferer stated adverse impact of migraine on their daily living (12). There are plenty of studies on the effect of therapeutic or prophylactic management of the migraine on HRQOL.…”

Section: Introductionmentioning

confidence: 99%

Quality of Life of Migraine Patients Treated With Combined Propranolol and Topiramate

et al. 2014

View full text Add to dashboard Cite

Background:Migraine is a chronic neurological disorder, which affects the quality of life (QOL). The burden of this disease could be improved by adequate prophylactic treatment. Objectives: We aimed to assess the quality of life in patients with migraine treated with both propranolol and topiramate in Shiraz, Iran. Patients and Methods:In this interventional study, we enrolled 100 newly diagnosed migraine patients who were referred to multidisciplinary clinic of Motahari in Shiraz. Reliable and valid Persian SF-36 questionnaire were used for the evaluation of baseline health-related QOL (HRQOL) and after treatment with 25 mg topiramate (twice daily) and 20 mg propranolol (three times daily) as prophylactic treatment. We used SPSS version 13 for data entry and analysis. Results: Scale differences were statistically significant in all scales before and after the intervention, except in vitality scale. After treatment, the highest score belonged to physical problem and the lowest one was emotional problem. Men had significantly higher scores in body pain compared to women (P = 0.039). Conclusions: Combined migraine prophylaxis with propranolol and topiramate improved HRQOL in migraine sufferers in our study. Adequate prophylaxis improved especially physical problem scale, which manifests with better performing activity and work. More study on the effect of monotherapy along with combined therapy with different doses on HRQOL may be helpful to further evaluate this effect.

show abstract

Anxiety and depression associated with migraine: Influence on migraine subjects' disability and quality of life, and acute migraine management

Cited by 283 publications

References 28 publications

Health-related quality of life among Canadians with migraine

Health-related quality of life among Canadians with migraine

A Review of Screening Tools for Psychiatric Comorbidity in Headache Patients

Quality of Life of Migraine Patients Treated With Combined Propranolol and Topiramate

Contact Info

Product

Resources

About